CLASS ACTIONS
PRODUCTS LIABILITY CASE: PREMPRO: DEFECTIVE DRUG WITH RISK OF BREAST CANCER
We have commenced filing a lawsuit again the manufacturer of PREMPRO and are preparing a class action. According to the complaint, the manufacturers Wyeth and Pfizer failed to warn of the risks of breast cancer and knew their product was defective. Recently in November 2009 an Illinois jury awarded a Plaintiff $75 million dollars. Later, in February 2010, a jury in Philadelphia awarded a plaintiff a $9 million dollar award. Prempro was linked by a study in 2002 called the Women's Health Initiative that suggested the increased risk of breast cancer for Prempro.
If you have been diagnosed with cancer after having been prescribed PREMPRO, or have a relative or loved one who has passed away from breast Cancer related to the use of PREMPRO, please contact the firm to discuss the case. Prempro was manufactured by Wyeth, which has been bought out by Pfizer.
PRODUCTS LIABILITY
The firm has filed a complaint against Walgreens for products liability as a result of failing to warn of the potential side affects of strokes for an over the counter nasal decongestant containing: PSEUDOEPHEDRINE. If you have had any similar injury related to over the count nasal decongestant medication, we urge you to contact us.
CLASS ACTION FOR SINGULAIR SIDE AFFECTS
The firm is in the process of preparing a class action products liability lawsuit against the manufacturer (MERCK & Co Inc.) of Singulair for failure to warn and for strict liability related to the FDA’s 2009 investigation linking Singulair to such psychiatric side affects as depression and attempted suicide attempts in minors. If you have had similar experience or your child has, contact us immediately to share your experience
As per the warnings by for Singulair:
Neuropsychiatric events have been reported in adult, adolescent, and pediatric patients taking SINGULAIR. Post-marketing reports with SINGULAIR use include agitation, aggressive behavior or hostility, anxiousness, depression, dream abnormalities, hallucinations, insomnia, irritability, restlessness, somnambulism, suicidal thinking and behavior (including suicide), and tremor. The clinical details of some post-marketing reports involving SINGULAIR appear consistent with a drug-induced effect.
Patients and prescribers should be alert for neuropsychiatric events. Patients should be instructed to notify their prescriber if these changes occur. Prescribers should carefully evaluate the risks and benefits of continuing treatment with SINGULAIR if such events occur (see ADVERSE REACTIONS, Post-Marketing Experience)
Further Singulair warnings state:
Post-Marketing Experience
The following additional adverse reactions have been reported in post-marketing use:
Blood and lymphatic system disorders: increased bleeding tendency
16 SINGULAIR® XXXXXXX (Montelukast Sodium) Tablets, Chewable Tablets, and Oral Granules
Immune system disorders: hypersensitivity reactions including anaphylaxis, very rarely hepatic eosinophilic infiltration
Psychiatric disorders: agitation including aggressive behavior or hostility, anxiousness, depression, dream abnormalities, hallucinations, insomnia, irritability, restlessness, somnambulism, suicidal thinking and behavior (including suicide), tremor (see PRECAUTIONS, Neuropsychiatric Events)
Patient medicine guides state the following are potential side affects:
Behavior and mood-related changes have been reported: agitation including aggressive behavior or hostility, bad/vivid dreams, depression, feeling anxious, hallucinations (seeing things that are not there), irritability, restlessness, sleep walking, suicidal thoughts and actions (including suicide), tremor, trouble sleeping. Tell your doctor if you experience behavior or mood-related changes while taking SINGULAIR.
PENDING LITIGATION
The firm is representing a Plaintiff against Progress Energy for injuries leading to amputation of a limb as a result of an electrical fire in Pinellas County. If you have had any similar experience or complaint to Progress Energy, we urge you to contact us.
We currently have many cases in the areas of medical malpractice, personal injuries, wrongful termination, workers' compensation, and various labor and employment cases such as whistleblower claims.
Contact us on any case involving Singulair and Amiodarone (Pacerone or Cordarone) and to inquire about our pending cases.
